Galectin Therapeutics Inc Annual Shareholders Meeting Transcript
Welcome to the Annual Meeting for Galectin Therapeutics, Inc. Our host for today's call is Kevin Freeman, Vice Chairman. At this time, all participants will be in a listen-only mode.
I will now turn the call over to your host, Mr. Freeman. You may begin, sir.
Good morning, ladies and gentlemen. Welcome. My name is Kevin Freeman. I am the Vice Chairman of the Board of Galectin Therapeutics, Inc. I will act as the Chair of this meeting, and Mr. Jack Callicutt, our Chief Financial Officer and Corporate Secretary, will act as Secretary.
Due to the ongoing COVID-19 pandemic, we are holding this year's Annual Meeting as a virtual meeting. Stockholders who require technical assistance during the meeting can call Broadridge's technical support line at the number listed on our virtual meeting website. Thank you.
I hereby call the 2021 Annual Meeting for Galectin Therapeutics, Inc. to order. At this time, I would like to introduce the current members of the Board of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |